1. Home
  2. 2024-09-22
  3. 2024-09-21
  4. 2024-09-20
  5. 2024-09-19
  6. 2020-12-05
  7. 2020-04-18
  8. 2019-11-30
  9. 2021-12-04
  10. 2019-12-14
  11. 2020-01-17
  1. Home
  2. delmar hamblin
  3. Experimental Hematology Group - VHIO
Experimental Hematology Group - VHIO

Experimental Hematology Group - VHIO

4.8
(544)
$ 14.00 In stock

Product Description

Experimental Hematology Group - VHIO
Single-Agent Divarasib (GDC-6036) in Solid Tumors with a KRAS G12C
Experimental Hematology Group - VHIO
A pan-cancer clinical platform to predict immunotherapy outcomes
Experimental Hematology Group - VHIO
Germline and Somatic Variants Co-Ocurrence Profile in Early Onset
Experimental Hematology Group - VHIO
Building a network of TP53 and IGHV testing reference centers
Experimental Hematology Group - VHIO
PDF) COVID-19 infection in adult patients with hematological
Experimental Hematology Group - VHIO
PET‐based radiomics signature can predict durable responses to CAR
Experimental Hematology Group - VHIO
Clara López Serrano - Clinical Trial Associate - Fortrea
Experimental Hematology Group - VHIO
Patricia Fernández Guzmán - PhD Student - Vall d'Hebron Institute
Experimental Hematology Group - VHIO
Young oncologists' perspective on the role and future of the
Experimental Hematology Group - VHIO
Single-Agent Divarasib (GDC-6036) in Solid Tumors with a KRAS G12C
Experimental Hematology Group - VHIO
Haematologica. Volume 108, Issue 3 by Haematologica - Issuu
Experimental Hematology Group - VHIO
GROUP: Translational Control and Cancer Stem Cells in Colorectal

Related products

You may also like

copyright © 2019-2024 edoardojannone.com all rights reserved.